These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 24308577)

  • 1. Rotavirus vaccination in Brazil: effectiveness and health impact seven years post-introduction.
    Linhares AC; Justino MC
    Expert Rev Vaccines; 2014 Jan; 13(1):43-57. PubMed ID: 24308577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential intussusception risk versus health benefits from rotavirus vaccination in Latin America.
    Desai R; Parashar UD; Lopman B; de Oliveira LH; Clark AD; Sanderson CF; Tate JE; Matus CR; Andrus JK; Patel MM
    Clin Infect Dis; 2012 May; 54(10):1397-405. PubMed ID: 22431803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rotavirus vaccines: a story of success.
    Kollaritsch H; Kundi M; Giaquinto C; Paulke-Korinek M
    Clin Microbiol Infect; 2015 Aug; 21(8):735-43. PubMed ID: 25680314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule.
    Buttery JP; Lambert SB; Grimwood K; Nissen MD; Field EJ; Macartney KK; Akikusa JD; Kelly JJ; Kirkwood CD
    Pediatr Infect Dis J; 2011 Jan; 30(1 Suppl):S25-9. PubMed ID: 21183837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rotavirus vaccination: a concise review.
    Vesikari T
    Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():57-63. PubMed ID: 22882248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rotavirus disease burden, Nicaragua 2001-2005: defining the potential impact of a rotavirus vaccination program.
    Amador JJ; Vasquez J; Orozco M; Pedreira C; Malespin O; De Oliveira LH; Tate J; Parashar U; Patel M
    Int J Infect Dis; 2010 Jul; 14(7):e592-5. PubMed ID: 20022778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of rotavirus vaccination on diarrhea-related hospitalizations in São Paulo State, Brazil.
    Fernandes EG; Sato HK; Leshem E; Flannery B; Konstantyner TC; Veras MA; Patel MM
    Vaccine; 2014 Jun; 32(27):3402-8. PubMed ID: 24736002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective hospital based surveillance of intussusception in children in a sentinel paediatric hospital: benefits and pitfalls for use in post-marketing surveillance of rotavirus vaccines.
    Lloyd-Johnsen C; Justice F; Donath S; Bines JE
    Vaccine; 2012 Apr; 30 Suppl 1():A190-5. PubMed ID: 22520131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of the monovalent G1P[8] human rotavirus vaccine against hospitalization for severe G2P[4] rotavirus gastroenteritis in Belém, Brazil.
    Justino MC; Linhares AC; Lanzieri TM; Miranda Y; Mascarenhas JD; Abreu E; Guerra SF; Oliveira AS; da Silva VB; Sanchez N; Meyer N; Shafi F; Ortega-Barria E; Soriano-Gabarró M; Colindres RE
    Pediatr Infect Dis J; 2011 May; 30(5):396-401. PubMed ID: 21150692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Broadening the age restriction for initiating rotavirus vaccination in regions with high rotavirus mortality: benefits of mortality reduction versus risk of fatal intussusception.
    Patel MM; Clark AD; Glass RI; Greenberg H; Tate J; Santosham M; Sanderson CF; Steele D; Cortese M; Parashar UD
    Vaccine; 2009 May; 27(22):2916-22. PubMed ID: 19428901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct and indirect effects of rotavirus vaccination upon childhood hospitalizations in 3 US Counties, 2006-2009.
    Payne DC; Staat MA; Edwards KM; Szilagyi PG; Weinberg GA; Hall CB; Chappell J; Curns AT; Wikswo M; Tate JE; Lopman BA; Parashar UD;
    Clin Infect Dis; 2011 Aug; 53(3):245-53. PubMed ID: 21705316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Projected health impact and cost-effectiveness of rotavirus vaccination among children <5 years of age in China.
    Liu N; Yen C; Fang ZY; Tate JE; Jiang B; Parashar UD; Zeng G; Duan ZJ
    Vaccine; 2012 Nov; 30(48):6940-5. PubMed ID: 22705174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of the pentavalent rotavirus vaccine (PRV), RotaTeq(®), in Kenya, including among HIV-infected and HIV-exposed infants.
    Laserson KF; Nyakundi D; Feikin DR; Nyambane G; Cook E; Oyieko J; Ojwando J; Rivers SB; Ciarlet M; Neuzil KM; Breiman RF
    Vaccine; 2012 Apr; 30 Suppl 1():A61-70. PubMed ID: 22520138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rotavirus vaccines in Belgium: policy and impact.
    Braeckman T; Van Herck K; Raes M; Vergison A; Sabbe M; Van Damme P
    Pediatr Infect Dis J; 2011 Jan; 30(1 Suppl):S21-4. PubMed ID: 21183836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rotavirus vaccination in Central American children.
    Ulloa-Gutierrez R; Avila-Aguero ML
    Expert Rev Vaccines; 2014 Jun; 13(6):687-90. PubMed ID: 24702467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of rotavirus vaccination programs in Taiwan.
    Chang WC; Yen C; Chi CL; Wu FT; Huang YC; Lin JS; Huang FC; Tate JE; Wu HS; Hsiung CA
    Vaccine; 2013 Nov; 31(46):5458-65. PubMed ID: 24060569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A benefit-risk analysis of rotavirus vaccination, France, 2015.
    Lamrani A; Tubert-Bitter P; Hill C; Escolano S
    Euro Surveill; 2017 Dec; 22(50):. PubMed ID: 29258644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Public finance of rotavirus vaccination in India and Ethiopia: an extended cost-effectiveness analysis.
    Verguet S; Murphy S; Anderson B; Johansson KA; Glass R; Rheingans R
    Vaccine; 2013 Oct; 31(42):4902-10. PubMed ID: 23871824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained low hospitalization rates after four years of rotavirus mass vaccination in Austria.
    Paulke-Korinek M; Kollaritsch H; Aberle SW; Zwazl I; Schmidle-Loss B; Vécsei A; Kundi M
    Vaccine; 2013 May; 31(24):2686-91. PubMed ID: 23597718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential intussusception risk versus benefits of rotavirus vaccination in the United States.
    Desai R; Cortese MM; Meltzer MI; Shankar M; Tate JE; Yen C; Patel MM; Parashar UD
    Pediatr Infect Dis J; 2013 Jan; 32(1):1-7. PubMed ID: 22929172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.